JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SCU
2501
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $4.06M | ﹤0.01% |
313,990
-24,158
| -7% | -$310K |
2013 Q2
28 quarters
|
|
2502
Quanta Services
PWR
$108B
| $4.06M | ﹤0.01% |
103,443
+4,412
| +4% | +$157K |
2013 Q2
28 quarters
|
|
2503
CALL
Peloton Interactive
PTON
$2.15B
| $4.04M | ﹤0.01% |
70,000
-97,100
| -58% | -$4.02M |
2019 Q4
2 quarters
|
|
|
JHG
2504
DELISTED
Janus Henderson
JHG
| $4.04M | ﹤0.01% |
190,991
-69,034
| -27% | -$1.33M |
2017 Q2
12 quarters
|
|
|
VG
2505
DELISTED
Vonage Holdings Corporation
VG
| $4.04M | ﹤0.01% |
401,668
-549,441
| -58% | -$4.93M |
2013 Q2
28 quarters
|
|
2506
CALL
Tenet Healthcare
THC
$21B
| $4.04M | ﹤0.01% |
223,000
+220,000
| +7,333% | +$4.33M |
2019 Q1
5 quarters
|
|
|
PGTI
2507
DELISTED
PGT, Inc.
PGTI
| $4.04M | ﹤0.01% |
257,533
+71,455
| +38% | +$859K |
2016 Q1
17 quarters
|
|
2508
PUT
US Bancorp Series B Preferred Stock
USB.PRH
$730M
| $4.04M | ﹤0.01% |
109,600
| – | – |
2018 Q2
8 quarters
|
|
2509
PUT
United Airlines
UAL
$36.2B
| $4.03M | ﹤0.01% |
116,500
+101,900
| +698% | +$3.06M |
2017 Q2
12 quarters
|
|
2510
PUT
MongoDB
MDB
$29.1B
| $4.03M | ﹤0.01% |
17,800
-57,200
| -76% | -$10.6M |
2020 Q1
1 quarter
|
|
2511
Voyager Therapeutics
VYGR
$150M
| $4.02M | ﹤0.01% |
318,663
+27,286
| +9% | +$317K |
2017 Q3
11 quarters
|
|
2512
Interparfums
IPAR
$3.62B
| $4.02M | ﹤0.01% |
83,484
-15,094
| -15% | -$680K |
2013 Q2
28 quarters
|
|
2513
Assured Guaranty
AGO
$3.03B
| $4.02M | ﹤0.01% |
164,556
+7,262
| +5% | +$198K |
2013 Q2
28 quarters
|
|
|
ADAP
2514
PUT
DELISTED
Adaptimmune Therapeutics
ADAP
| $4M | ﹤0.01% |
+400,000
| New | +$2.51M |
2020 Q2
0 quarters
|
|
2515
CALL
Chevron
CVX
$409B
| $4M | ﹤0.01% |
44,800
-27,600
| -38% | -$2.47M |
2014 Q3
23 quarters
|
|
|
FNHC
2516
DELISTED
FedNat Holding Company Common Stock
FNHC
| $3.99M | ﹤0.01% |
360,669
+171,555
| +91% | +$2M |
2016 Q4
14 quarters
|
|
2517
CALL
Archer Daniels Midland
ADM
$39.6B
| $3.99M | ﹤0.01% |
100,000
| – | – |
2018 Q2
8 quarters
|
|
2518
PUT
ADT
ADT
$4.65B
| $3.99M | ﹤0.01% |
500,000
| – | – |
2019 Q3
3 quarters
|
|
2519
Utah Medical Products
UTMD
$235M
| $3.98M | ﹤0.01% |
44,920
+29,182
| +185% | +$2.62M |
2015 Q3
19 quarters
|
|
2520
Century Aluminum
CENX
$3.67B
| $3.98M | ﹤0.01% |
557,627
-1,085,083
| -66% | -$5.74M |
2013 Q2
28 quarters
|
|
|
LNW
2521
DELISTED
Light & Wonder
LNW
| $3.97M | ﹤0.01% |
256,955
-227,116
| -47% | -$2.97M |
2013 Q2
28 quarters
|
|
2522
Liberty Media Corporation Series C Common Stock
FWONK
$23.9B
| $3.97M | ﹤0.01% |
129,351
+86,911
| +205% | +$2.58M |
2014 Q3
23 quarters
|
|
|
GOOS
2523
PUT
Canada Goose Holdings
GOOS
$750M
| $3.96M | ﹤0.01% |
171,000
| – | – |
2020 Q1
1 quarter
|
|
|
BPFH
2524
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $3.96M | ﹤0.01% |
575,178
+106,595
| +23% | +$746K |
2013 Q2
28 quarters
|
|
|
BFS
2525
Saul Centers
BFS
$736M
| $3.95M | ﹤0.01% |
122,357
-33,989
| -22% | -$1.08M |
2013 Q2
28 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.